reference/15541845

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/15541845

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
endingPage	402
issn	1557-3265 1078-0432
issueIdentifier	1
pageRange	390-402
publicationName	Clinical cancer research : an official journal of the American Association for Cancer Research
startingPage	390
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_15a794747b6ede09ca613b864abab056
bibliographicCitation	Rubio C, Martínez-Fernández M, Segovia C, Lodewijk I, Suarez-Cabrera C, Segrelles C, López-Calderón F, Munera-Maravilla E, Santos M, Bernardini A, García-Escudero R, Lorz C, Gómez-Rodriguez MJ, de Velasco G, Otero I, Villacampa F, Guerrero-Ramos F, Ruiz S, de la Rosa F, Domínguez-Rodríguez S, Real FX, Malats N, Castellano D, Dueñas M, Paramio JM. CDK4/6 Inhibitor as a Novel Therapeutic Approach for Advanced Bladder Cancer Independently of RB1 Status. Clin Cancer Res. 2019 Jan 01;25(1):390–402. doi: 10.1158/1078-0432.ccr-18-0685. PMID: 30242024.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_38294f735d5afc60d2593ddc1dc92fa4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e2066483e8d9792ccc6d92a6ea37daed http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c2e66e5e05c3c85a4df0377e240c0f80 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-0177-6965 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-0857-9726 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-5722-9904 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b47c799647071f9bbeff8584f7f1e28e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0ae9c9a048ac83d1818945597c02acf4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a786bc64453221f907a040035048b308 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_83e51fa5cc04218a9d3c8f26edebe455 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_766dc6913cd5a8316a1fed1bbae2a6ae http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-0767-3465 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0909fae066646f580df7d98d81055913 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-7520-3177 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6e48e9e6b902cf51bb6300451f55e139 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-5208-8249 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b88895b289b4035b8b329ed332821060 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_498f14ce51ff763eb10d8ebdba2e0734 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-5640-6542 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_17b02dcb4db6cb9749d8b9332d483a23 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_07ff8828d995326557d8228adfbff945 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-2494-7587 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9f19a6dcf68d6594a73abd99b3caa7c8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c0f7eba372c1ba6f88a70789d022853d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4379d8fd538acfeff4b0bd01929b2dbc http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-8214-9076 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_89b6ce1e5107f72c365b173cd1e4eb21 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-6779-6945 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f91c7fd64a9b03c97121df378f63e4a6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2905376a75beae292fc3efe8aa42f443
date	2019-01-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/30242024 https://doi.org/10.1158/1078-0432.ccr-18-0685
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8794 https://portal.issn.org/resource/ISSN/1078-0432 https://portal.issn.org/resource/ISSN/1557-3265
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	CDK4/6 Inhibitor as a Novel Therapeutic Approach for Advanced Bladder Cancer Independently of RB1 Status
discusses	http://id.nlm.nih.gov/mesh/M0004505 http://id.nlm.nih.gov/mesh/M0279832 http://id.nlm.nih.gov/mesh/M0480269 http://id.nlm.nih.gov/mesh/M0208277 http://id.nlm.nih.gov/mesh/M0446168 http://id.nlm.nih.gov/mesh/M0474139 http://id.nlm.nih.gov/mesh/M000616723 http://id.nlm.nih.gov/mesh/M000616464 http://id.nlm.nih.gov/mesh/M0228003 http://id.nlm.nih.gov/mesh/M0457532 http://id.nlm.nih.gov/mesh/M0526868
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000072278Q000235 http://id.nlm.nih.gov/mesh/D051358Q000235 http://id.nlm.nih.gov/mesh/D051361Q000235 http://id.nlm.nih.gov/mesh/D001749Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D009364Q000188 http://id.nlm.nih.gov/mesh/D009364Q000473 http://id.nlm.nih.gov/mesh/D000077982 http://id.nlm.nih.gov/mesh/D064593 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D010766Q000187 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D017209Q000187 http://id.nlm.nih.gov/mesh/D056286Q000235 http://id.nlm.nih.gov/mesh/D045744 http://id.nlm.nih.gov/mesh/D002945Q000494 http://id.nlm.nih.gov/mesh/D001749Q000235 http://id.nlm.nih.gov/mesh/D051361Q000037 http://id.nlm.nih.gov/mesh/D051358Q000037 http://id.nlm.nih.gov/mesh/D009364Q000235 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D001749Q000473 http://id.nlm.nih.gov/mesh/D049109Q000187 http://id.nlm.nih.gov/mesh/D047428Q000494 http://id.nlm.nih.gov/mesh/D044767Q000235 http://id.nlm.nih.gov/mesh/D008297
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_9455a7be1a7c0dbb6de4ba8898dff00c http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7053 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_63a9c446da97985db610d03a02fcdbd9 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11431 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5702198 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1019 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1021 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2305

Total number of triples: 98.